M&T Bank’s CVS Health CVS Stock Holding History

M&T Bank’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.4M	Sell	144,543 -7,225	-5%	-$557K	0.04%	286
2025 Q4	$12M	Buy	151,768 +13,943	+10%	+$1.1M	0.04%	269
2025 Q3	$10.4M	Sell	137,825 -26,818	-16%	-$1.84M	0.03%	274
2025 Q2	$11.4M	Sell	164,643 -16,646	-9%	-$1.09M	0.04%	273
2025 Q1	$12.3M	Sell	181,289 -17,012	-9%	-$1.02M	0.04%	256
2024 Q4	$8.9M	Sell	198,301 -94,483	-32%	-$5.3M	0.03%	318
2024 Q3	$18.4M	Sell	292,784 -89,968	-24%	-$5.25M	0.06%	219
2024 Q2	$22.6M	Sell	382,752 -726,270	-65%	-$45.4M	0.08%	188
2024 Q1	$88.5M	Buy	1,109,022 +12,490	+1%	+$954K	0.31%	71
2023 Q4	$86.6M	Buy	1,096,532 +88,196	+9%	+$6.28M	0.32%	73
2023 Q3	$70.4M	Sell	1,008,336 -18,386	-2%	-$1.3M	0.28%	85
2023 Q2	$71M	Sell	1,026,722 -28,019	-3%	-$1.99M	0.26%	89
2023 Q1	$78.4M	Sell	1,054,741 -32,113	-3%	-$2.69M	0.3%	81
2022 Q4	$101M	Buy	1,086,854 +24,926	+2%	+$2.41M	0.41%	63
2022 Q3	$101M	Buy	1,061,928 +15,203	+1%	+$1.5M	0.45%	54
2022 Q2	$90.7M	Buy	1,046,725 +68,095	+7%	+$6.65M	0.43%	56
2022 Q1	$99M	Buy	978,630 +53,462	+6%	+$5.62M	0.44%	55
2021 Q4	$95.4M	Buy	925,168 +7,182	+0.8%	+$664K	0.4%	59
2021 Q3	$77.9M	Buy	917,986 +5,415	+0.6%	+$454K	0.35%	70
2021 Q2	$76.1M	Sell	912,571 -63,596	-7%	-$5.21M	0.33%	74
2021 Q1	$73.4M	Sell	976,167 -3,176	-0.3%	-$231K	0.32%	77
2020 Q4	$66.9M	Sell	979,343 -49,267	-5%	-$3.2M	0.29%	78
2020 Q3	$60.1M	Sell	1,028,610 -5,255	-0.5%	-$327K	0.29%	84
2020 Q2	$67.2M	Sell	1,033,865 -45,335	-4%	-$2.85M	0.36%	66
2020 Q1	$64M	Buy	1,079,200 +13,194	+1%	+$881K	0.38%	62
2019 Q4	$79.2M	Buy	1,066,006 +5,569	+0.5%	+$391K	0.37%	50
2019 Q3	$66.9M	Sell	1,060,437 -33,039	-3%	-$1.96M	0.33%	78
2019 Q2	$59.6M	Sell	1,093,476 -7,759	-0.7%	-$418K	0.31%	91
2019 Q1	$59.4M	Buy	1,101,235 +90,944	+9%	+$5.61M	0.31%	85
2018 Q4	$66.2M	Buy	1,010,291 +31,251	+3%	+$2.33M	0.38%	62
2018 Q3	$77.1M	Buy	979,040 +129,559	+15%	+$9.26M	0.39%	61
2018 Q2	$54.7M	Buy	849,481 +574,683	+209%	+$37.9M	0.29%	86
2018 Q1	$17.1M	Buy	274,798 +13,811	+5%	+$991K	0.09%	188
2017 Q4	$18.9M	Sell	260,987 -32,340	-11%	-$2.35M	0.1%	183
2017 Q3	$23.9M	Buy	293,327 +2,936	+1%	+$232K	0.13%	153
2017 Q2	$23.4M	Sell	290,391 -3,843	-1%	-$303K	0.14%	155
2017 Q1	$23.1M	Sell	294,234 -22,918	-7%	-$1.83M	0.14%	154
2016 Q4	$25M	Sell	317,152 -276,514	-47%	-$22.4M	0.16%	139
2016 Q3	$52.8M	Sell	593,666 -21,740	-4%	-$2.05M	0.34%	78
2016 Q2	$58.9M	Sell	615,406 -13,140	-2%	-$1.31M	0.4%	59
2016 Q1	$65.2M	Buy	628,546 +41,364	+7%	+$4.02M	0.44%	53
2015 Q4	$57.4M	Sell	587,182 -10,704	-2%	-$1.05M	0.38%	65
2015 Q3	$57.7M	Sell	597,886 -28,049	-4%	-$2.95M	0.39%	57
2015 Q2	$65.6M	Buy	625,935 +31,305	+5%	+$3.2M	0.4%	57
2015 Q1	$61.4M	Buy	594,630 +43,289	+8%	+$4.38M	0.38%	56
2014 Q4	$53.1M	Buy	551,341 +93,672	+20%	+$8.25M	0.33%	65
2014 Q3	$36.4M	Buy	457,669 +376,441	+463%	+$29.7M	0.23%	87
2014 Q2	$6.12M	Sell	81,228 -2,116	-3%	-$160K	0.26%	80
2014 Q1	$6.24M	Sell	83,344 -4,218	-5%	-$298K	0.26%	83
2013 Q4	$6.27M	Buy	87,562 +3,122	+4%	+$201K	0.26%	82
2013 Q3	$4.79M	Buy	84,440 +7,536	+10%	+$449K	0.23%	92
2013 Q2	$4.4M	Buy	+76,904	New	+$4.46M	0.21%	96

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

M&T Bank's CVS Position: Q1 2026 in Review

M&T Bank reduced its CVS Health (CVS) stake by 4.8% in Q1 2026, selling an estimated $557K and leaving 144,543 shares worth $10.4M. The position accounts for 0.04% of the portfolio, ranked #286.

M&T Bank first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $101M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

M&T Bank held 144,543 shares of CVS Health worth $10.4M as of Q1 2026.
M&T Bank sold 7,225 CVS Health shares in Q1 2026, an estimated $557K.
CVS Health made up 0.04% of M&T Bank's portfolio in Q1 2026, its #286 holding.
M&T Bank first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
M&T Bank's CVS Health position peaked at $101M in Q3 2022.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.